Global Neuroprotective Agents Market Size, Trends & Analysis - Forecasts To 2026

Global Neuroprotective Agents Market Size, Trends & Analysis - Forecasts To 2026

By Drug (Cholinesterase Inhibitors, Anti-inflammatory & Anti-apoptotic Agents, NMDA Receptor Antagonists, Neurotropic Factors, Mitochondrial Dysfunction Regulators, Free Radical Trappers, Anti-excitotoxic Agents, Others), By Indication (Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, Huntington's Disease, Neuropathies, Brain Injury, Others), By Region (North America, Europe, Asia Pacific and Rest of the World), Vendor Landscape, End User Landscape and Company Market Share Analysis & -Competitor Analysis

Neuroprotective Agents Market: Insights

The global neuroprotective agents market is estimated to witness a significant CAGR during the forecast period (2020-2026). Growing incidence and prevalence of neurodegenerative diseases along with rise in stroke and traumatic central nervous system injuries are some of the major factors expected to drive the market growth during the forecast period. 

Request a free sample copy of the report @https://www.globalmarketestimates.com/market-report/global-neuroprotective-agents-market-2090 

Neuroprotective Agents Market: By Drug

On the basis of drug, the global neuroprotective agents market is segmented into cholinesterase inhibitors, anti-inflammatory & anti-apoptotic agents, NMDA receptor antagonists, neurotropic factors, mitochondrial dysfunction regulators, free radical trappers, and anti-excitotoxic agents, among others. The report contains quantitative insights about the following:

1.1.  Introduction 

1.1.1.     Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)      

1.2.  Cholinesterase Inhibitors   

1.2.1.     Cholinesterase Inhibitors: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.3.  Anti-inflammatory & Anti-apoptotic Agents        

1.3.1.     Anti-inflammatory & Anti-apoptotic Agents: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.4.  NMDA Receptor Antagonists         

1.4.1.     NMDA Receptor Antagonists: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.5.  Neurotropic Factors

1.5.1.     Neurotropic Factors: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.6.  Mitochondrial Dysfunction Regulators     

1.6.1.     Mitochondrial Dysfunction Regulators: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.7.  Free Radical Trappers         

1.7.1.     Free Radical Trappers: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.8.  Anti-excitotoxic Agents       

1.8.1.     Anti-excitotoxic Agents: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.9.  Others           

1.9.1.     Others: Neuroprotective Agents Market, 2020-2026 (USD Million) 

Neuroprotective Agents Market: By Indication

On the basis indication, the global neuroprotective agents market is segmented into alzheimer's disease, multiple sclerosis, parkinson's disease, huntington's disease, neuropathies, and brain injury, among others. The report contains quantitative insights about the following:

1.1.  Introduction

1.1.1.     Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)         

1.2.  Alzheimer's Disease

1.2.1.     Alzheimer's Disease: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.3.  Multiple Sclerosis    

1.3.1.     Multiple Sclerosis: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.4.  Parkinson's Disease           

1.4.1.     Parkinson's Disease: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.5.  Huntington's Disease          

1.5.1.     Huntington's Disease: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.6.  Brain Injury  

1.6.1.     Brain Injury: Neuroprotective Agents Market, 2020-2026 (USD Million)

1.7.  Others           

1.7.1.     Others: Neuroprotective Agents Market, 2020-2026 (USD Million)

Neuroprotective Agents Market: By Region

On the basis of region, the global neuroprotective agents market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The countries covered include: U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Saudi Arabia, UAE, and South Africa among others. The report provides qualitative & quantitative insights both at a regional as well as country level.

 

1.1.  Introduction 

1.1.1.     Global Neuroprotective Agents Market, By Region, 2020-2026 (USD Million)  

1.2.  North America         

1.2.1.     By Drug          

1.2.1.1.          North America Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    

1.2.2.     By Indication 

1.2.2.1.          North America Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)      

1.2.3.     By Country     

1.2.3.1.          U.S     

1.2.3.1.1.                By Drug          

1.2.3.1.1.1.                     U.S Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)  

1.2.3.1.2.                By Indication 

1.2.3.1.2.1.                     U.S Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 

1.2.3.2.          Canada          

1.2.3.2.1.                By Drug          

1.2.3.2.1.1.                     Canada Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 

1.2.3.2.2.                By Indication 

1.2.3.2.2.1.                     Canada Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 

1.2.3.3.          Mexico           

1.2.3.3.1.                By Drug          

1.2.3.3.1.1.                     Mexico Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)  

1.2.3.3.2.                By Indication 

1.2.3.3.2.1.                     Mexico Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 

1.3.  Europe          

1.3.1.     By Drug          

1.3.1.1.          Europe Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     

1.3.2.     By Indication 

1.3.2.1.          Europe Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)        

1.3.3.     By Country     

1.3.3.1.          Germany        

1.3.3.1.1.                By Drug          

1.3.3.1.1.1.                     Germany Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 

1.3.3.1.2.                By Indication 

1.3.3.1.2.1.                     Germany Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 

1.3.3.2.          UK      

1.3.3.2.1.                By Drug          

1.3.3.2.1.1.                     UK Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)

1.3.3.2.2.                By Indication 

1.3.3.2.2.1.                     UK Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 

1.3.3.3.          France

1.3.3.3.1.                By Drug          

1.3.3.3.1.1.                     France Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)  

1.3.3.3.2.                By Indication 

1.3.3.3.2.1.                     France Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)             

1.3.3.4.          Italy    

1.3.3.4.1.                By Drug          

1.3.3.4.1.1.                     Italy Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)  

1.3.3.4.2.                By Indication 

1.3.3.4.2.1.                     Italy Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 

1.3.3.5.          Rest Of Europe          

1.3.3.5.1.                By Drug          

1.3.3.5.1.1.                     Rest Of Europe Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 

1.3.3.5.2.                By Indication 

1.3.3.5.2.1.                     Rest Of Europe Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)   

1.4.  Asia Pacific  

1.4.1.     By Drug          

1.4.1.1.          Asia Pacific Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)         

1.4.1.2.          By Indication 

1.4.1.2.1.                Asia Pacific Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)         

1.4.1.3.          By Country     

1.4.1.3.1.                China 

1.4.1.3.1.1.                     By Drug          

1.4.1.3.1.1.1.   China Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     

1.4.1.3.1.2.                     By Indication 

1.4.1.3.1.2.1.   China Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)    

1.4.1.3.2.                Japan 

1.4.1.3.2.1.                     By Drug          

1.4.1.3.2.1.1.   Japan Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     

1.4.1.3.2.2.                     By Indication 

1.4.1.3.2.2.1.   Japan Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)    

1.4.1.3.3.                India  

1.4.1.3.3.1.                     By Drug          

1.4.1.3.3.1.1.   India Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     

1.4.1.3.3.2.                     By Indication 

1.4.1.3.3.2.1.   India Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)    

1.4.1.3.4.                Australia        

1.4.1.3.4.1.                     By Drug          

1.4.1.3.4.1.1.   Australia Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    

1.4.1.3.4.2.                     By Indication 

1.4.1.3.4.2.1.   Australia Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)                            

1.4.1.3.5.                Rest of APAC

1.4.1.3.5.1.                     By Drug          

1.4.1.3.5.1.1.   Rest of APAC Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    

1.4.1.3.5.2.                     By Indication 

1.4.1.3.5.2.1.   Rest of APAC Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)

1.5.  Middle East & Africa           

1.5.1.     By Drug          

1.5.1.1.          Middle East & Africa Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)      

1.5.2.     By Indication 

1.5.2.1.          Middle East & Africa Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)     

1.5.3.     By Country     

1.5.3.1.          Saudi Arabia 

1.5.3.1.1.                By Drug          

1.5.3.1.1.1.                     Saudi Arabia Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 

1.5.3.1.2.                By Indication 

1.5.3.1.2.1.                     Saudi Arabia Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)   

1.5.3.2.          UAE    

1.5.3.2.1.                By Drug          

1.5.3.2.1.1.                     UAE Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)  

1.5.3.2.2.                By Indication 

1.5.3.2.2.1.                     UAE Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 

1.6.  Central & South America   

1.6.1.     By Drug          

1.6.1.1.          Central & South America Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     

1.6.2.     By Indication 

1.6.2.1.          Central & South America Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)        

1.6.3.     By Country     

1.6.3.1.          Brazil 

1.6.3.1.1.                By Drug          

1.6.3.1.1.1.                     Brazil Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)  

1.6.3.1.2.                By Indication 

1.6.3.1.2.1.                     Brazil Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)  

Neuroprotective Agents Market: End User Landscape 

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products & services, and regional presence of companies who are purchasing or are likely to purchase neuroprotective agents. The key end-users of the markets are Mayo Clinic, AIIMS, and Foothill Medical, among others.

Neuroprotective Agents Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Neuroprotective Agents Market: Share & Competitor Analysis

Some of the key players operating in the neuroprotective agents market are GlaxoSmithKline Plc, Bayer Healthcare, Eisai Inc. Merck, Serono S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Genervon Biopharmaceuticals, NeuroVive Pharmaceutical, Ceregene, BHRPharma LLC, Neuren Pharmaceuticals, Allon therapeutics, Inc., Bionure Inc., among others.                                               

Browse the report @https://www.globalmarketestimates.com/market-report/global-neuroprotective-agents-market-2090